Our study found that HT patients had abnormal differentiation within CD4+T cell subpopulations, specifically an increase in the ratio of CD4+Th17/CD4+CD25+Treg cells, combined with elevated levels of fatty acid oxidation. The gene discussed is CD4; the disease is hematocrit.